Inevitable Ventures

Inevitable Ventures is a company.

Active

Updated: Mar 18, 2026 ·

About

Inevitable Ventures operates as an investment partnership and venture capital firm, focusing on early-stage opportunities. It provides capital at inception, actively collaborates with portfolio companies to co-build nascent products, and fosters strategic partnerships within leading hacker communities. This model supports the development of innovative solutions from their foundational stages.

The firm was established by billionaire investor Ron Burkle, seasoned venture capital fund manager Chris Hollod, and recording artist Dawson Wallach. Their collaboration is driven by a shared vision to identify and nurture groundbreaking innovation within the startup ecosystem. This diverse founding team brings a blend of financial acumen, investment expertise, and creative insight to their strategy.

Inevitable Ventures primarily serves early-stage founders and entrepreneurial teams seeking both capital and hands-on operational support. Its long-term vision centers on empowering a new generation of companies by providing essential resources and strategic guidance needed to transform innovative ideas into impactful businesses. It aims to be a foundational partner for future industry leaders.

Financial History

Total Raised

N/A

Valuation

N/A

Financial History

Total Raised

N/A

Valuation

N/A

Leadership Team

Key people at Inevitable Ventures.

Chris Hollod

Co-Founder

Leadership Team

Key people at Inevitable Ventures.

Chris Hollod

Co-Founder

Deep Dive

High-Level Overview

Inevitable Ventures is a Los Angeles-based investment partnership founded by billionaire investor Ron Burkle, VC fund manager Chris Hollod, and recording artist/investor D.A. Wallach. Its mission centers on supporting entrepreneurs tackling difficult problems in industries central to human life, such as healthcare, biotechnology, life sciences, financial services, food, logistics, media, e-commerce, and radical emerging technologies that create novel consumer experiences.[1][3][4][5] The firm's investment philosophy is opportunistic, focusing on breakthrough startups like Glympse Bio, Beam, Neuralink, Doctor on Demand, Devoted Health, and early bets on Spotify, SpaceX, and Ripple, with check sizes ranging from $500K to $10M across seed, Series A, and later rounds, primarily in the USA.[1][4][5] It has influenced the startup ecosystem through high-profile biotech and healthcare investments, achieving 2 portfolio exits including Glympse Bio in 2023, while providing targeted support for Southern California builders.[1][3][4]

A separate, newer entity named Inevitable Ventures, launched in 2025 and based in Bucharest, invests in early-stage European founders at the intersection of applied AI, robotics, and cyber-physical infrastructure; this analysis focuses on the primary LA firm given its established track record.[2]

Origin Story

Inevitable Ventures emerged from the converging expertise of its founders: Ron Burkle's billionaire investment acumen, Chris Hollod's VC management prowess, and D.A. Wallach's dual career as an acclaimed musician turned biotech-focused investor. Wallach shifted from touring in 2011 to VC, backing defining tech like Spotify and SpaceX before narrowing to biotech/healthcare since 2015 with investments in Neuralink and others.[1][4] The partnership formed to channel this blend into opportunistic bets on transformative tech, basing operations in Los Angeles with emphasis on local Southern California innovation; key early moves included 2016-2018 Series A/B investments like Glympse Bio ($22M round).[1][3][4]

Core Differentiators

Unique Investment Model: Opportunistic focus on "radical emerging technologies" solving hard problems in human-centric sectors, blending biotech/healthcare with media, finance, and logistics; invests across stages (seed to Series B+) with flexible check sizes ($500K-$10M).[1][4][5]
Network Strength: Founders' star power—Burkle's wealth, Hollod's fund expertise, Wallach's connections from music/tech (e.g., Spotify, SpaceX)—enables access to contrarian ideas like $100M biotech plans.[1][4]
Track Record: 5+ known investments with 2 exits (latest: Glympse Bio, 2023); prior hits include Neuralink, Beam, Devoted Health; strong in reinvention of medicine.[1][4][5]
Operating Support: Particular attention to LA/Southern California ecosystem, aiding entrepreneurs in healthcare/life sciences with hands-on backing for difficult, industry-defining challenges.[1][3]

Role in the Broader Tech Landscape

Inevitable Ventures rides the wave of biotech and healthcare reinvention amid accelerating tech convergence with biology, fueled by AI-driven drug discovery and longevity advances. Timing aligns with post-2020 biotech boom, where firms like Neuralink push human augmentation and firms like Glympse enable real-time disease detection.[1][4] Market forces favoring them include rising VC interest in "moonshot" therapies, Southern California's emerging biotech hub status challenging SF/NY dominance, and founders' networks unlocking mega-deals.[1][3] The firm influences the ecosystem by validating high-risk bets, bridging entertainment/tech talent into science, and fostering LA as a nexus for life sciences innovation.[1][4]

Quick Take & Future Outlook

Inevitable Ventures is poised to scale its biotech/healthcare focus amid AI-biotech synergies, potentially leading more Series A/B rounds in neurotech, precision medicine, and logistics automation. Trends like mRNA expansion (echoing portfolio pipelines) and cyber-physical systems will shape its path, with LA's growth amplifying influence.[1][2][4][5] As founders leverage personal brands for deal flow, expect evolving impact through exits and follow-ons, solidifying its role in human-life tech frontiers—echoing its core mission to back the inevitable.

Sources

Frequently Asked Questions

What is Inevitable Ventures' core investment thesis and technological focus?

Inevitable Ventures primarily invests at the intersection of applied artificial intelligence (AI), robotics, and cyber-physical infrastructure. Their objective is to lay the foundation for the next industrial era by backing companies in these critical technology sectors.

Who are the principal founders of Inevitable Ventures?

Inevitable Ventures was founded by a notable group including billionaire investor Ron Burkle, prominent VC fund manager Chris Hollod, and recording artist David Wallach. This investment partnership leverages their diverse expertise and networks.

What stage of companies does Inevitable Ventures typically invest in, and what unique support do they provide?

Inevitable Ventures operates as both a venture fund and an incubator, investing at the inception stage and co-building early products. Beyond capital, they provide network access, subject-matter expertise, and partner with leading hacker communities to support European founders and venture capitalists.

What are the primary geographic markets where Inevitable Ventures focuses its investment activities?

Inevitable Ventures demonstrates a strong focus on supporting founders and ventures across Europe, as indicated by their incubator activities and partnerships. While some sources suggest operations in the United States, their stated engagement often highlights the European startup ecosystem.